Medical Rationale
COPD produces cor pulmonale (right ventricular hypertrophy and failure) through chronic hypoxic pulmonary vasoconstriction. As COPD destroys alveolar architecture, ventilation-perfusion mismatch produces alveolar hypoxia that triggers contraction of pulmonary arteriolar smooth muscle — a protective reflex that becomes pathological when applied chronically across large areas of lung. Sustained hypoxic vasoconstriction causes pulmonary arterial remodeling: medial smooth muscle hypertrophy, intimal fibrosis, and in situ thrombosis progressively increase pulmonary vascular resistance. The right ventricle, designed for low-pressure circulation, develops compensatory hypertrophy but eventually fails under the sustained afterload. Loss of pulmonary capillary bed from emphysematous destruction further reduces cross-sectional vascular area and increases pulmonary pressures.
Key Studies
Weitzenblum E (2003) Heart (chronic cor pulmonale — pathophysiology); MacNee W (1994) Am J Respir Crit Care Med (right heart function in COPD — pathophysiology of cor pulmonale).
Filing Tips
Echocardiogram demonstrating right ventricular hypertrophy, elevated pulmonary artery systolic pressure (>35 mmHg), and/or right ventricular dysfunction. Right heart catheterization if available (definitive for pulmonary hypertension). Pulmonary function tests documenting severe COPD (FEV1 <50% predicted). Arterial blood gas showing chronic hypoxemia. Cardiology or pulmonology nexus letter addressing hypoxic pulmonary vasoconstriction mechanism. File under DC 7020 (cardiomyopathy) or consider under DC 7021 (hypertensive heart disease) depending on the predominant presentation. Cor pulmonale with right heart failure can warrant a 100% cardiac rating.